Alerts will be sent to your verified email
Verify EmailSAROJA
Saroja Pharma Ind
|
Link Pharma Chem
|
Venmax Drugs&Pharma
|
|
---|---|---|---|
Operational Metrics
|
|||
Financials
|
|||
5 yr Average ROE
|
33.33 % | 4.87 % | -44.32 % |
5yr average Equity Multiplier
|
4.66 | 1.96 | -0.19 |
5yr Average Asset Turnover Ratio
|
2.98 | 1.37 | 0.32 |
5yr Avg Net Profit Margin
|
2.08 % | 1.5 % | -30.94 % |
Price to Book
|
0.0 | 1.26 | 3.42 |
P/E
|
15.15 | 0.0 | 0.0 |
5yr Avg Cash Conversion Cycle
|
80.28 Days | 74.76 Days | 0.0 |
Inventory Days
|
11.27 Days | 54.27 Days | 24.83 Days |
Days Receivable
|
122.72 Days | 53.6 Days | 0.0 |
Days Payable
|
47.62 Days | 92.46 Days | 189.56 Days |
5yr Average Interest Coverage Ratio
|
2.76 | 3.51 | -318.36 |
5yr Avg ROCE
|
37.65 % | 8.64 % | -45.33 % |
5yr Avg Operating Profit Margin
|
4.76 % | 5.7 % | -50.41 % |
5 yr average Debt to Equity
|
1.78 | 0.46 | -0.64 |
5yr CAGR Net Profit
|
3.81 % | n/a | n/a |
5yr Average Return on Assets
|
6.13 % | 2.49 % | 187.49 % |
Shareholdings
|
|||
Promoter Holding
|
73.02 % | 51.49 % | 23.13 % |
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
Change in Promoter Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
Saroja Pharma Ind
|
Link Pharma Chem
|
Venmax Drugs&Pharma
|
|
---|---|---|---|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|